A. Montazeri

Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5‐fluorouracil and oral capecitabine

H. Wong, A. Sun Myint, V. S. Ramani, 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

personalised approach for patients with rectal cancer

R. Myerson, A. Myint, V. S. Ramani, 2012 .

Long‐term outcomes of real world ‘watch and wait’ data for rectal cancer after neoadjuvant chemoradiotherapy

D. Agbamu, A. Montazeri, C. Walsh, 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

The effect of combined resistance aerobic exercise training on concentrations of asprosin and complement C1q tumor necrosis factor-related protein-1 in men with type 2 diabetes

M. Zarei, A. Montazeri, Javad Nakhzari Khodakheyr, 2021, Sport Sciences for Health.

Post docetaxel treatment for castration-resistant prostate cancer (CRPC): Does sequencing matter?

Z. Malik, H. Wong, A. Montazeri, 2012 .

LBA21 Radioembolization with chemotherapy for colorectal liver metastases: A randomized, open-label, international, multicenter, phase III trial (EPOCH study)

C. Sofocleous, M. Mulcahy, P. Ross, 2021, Annals of Oncology.

Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial

Matthew S. Johnson, C. Sofocleous, Tae-You Kim, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant chemotherapy for rectal cancer: Is it needed?

K. Milinis, P. Rooney, A. Montazeri, 2015, World journal of clinical oncology.

Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma

I. McQuaker, A. Montazeri, J. Erskine, 2007, European journal of haematology.

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

V. Gebski, P. Gibbs, F. Lammert, 2017, The Lancet. Oncology.

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.

M. Parmar, M. Sydes, D. Dearnaley, 2023, The Lancet. Oncology.

Long‐term outcomes of patients with poor prognostic factors following transanal endoscopic microsurgery for early rectal cancer

Sarah Shamim, Shakil Ahmed, A. Montazeri, 2021, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.